154 related articles for article (PubMed ID: 37460380)
1. Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis.
McGarry ME; Huang CY; Ly NP
J Cyst Fibros; 2023 Sep; 22(5):909-915. PubMed ID: 37460380
[TBL] [Abstract][Full Text] [Related]
2. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.
Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H
J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431
[TBL] [Abstract][Full Text] [Related]
3. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
[TBL] [Abstract][Full Text] [Related]
5. Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.
McGarry ME; Huang CY; Nielson DW; Ly NP
J Cyst Fibros; 2021 May; 20(3):424-431. PubMed ID: 33162303
[TBL] [Abstract][Full Text] [Related]
6. Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?
Moore JE; Rendall JC; Millar BC
Infect Dis Health; 2023 Nov; 28(4):265-270. PubMed ID: 37258345
[TBL] [Abstract][Full Text] [Related]
7. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Jennings MT; Dasenbrook EC; Lechtzin N; Boyle MP; Merlo CA
J Cyst Fibros; 2017 Nov; 16(6):681-686. PubMed ID: 28446387
[TBL] [Abstract][Full Text] [Related]
9. Review: Staphylococcus aureus and MRSA in cystic fibrosis.
Goss CH; Muhlebach MS
J Cyst Fibros; 2011 Sep; 10(5):298-306. PubMed ID: 21719362
[TBL] [Abstract][Full Text] [Related]
10. Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.
Huang SS; Datta R; Rifas-Shiman S; Kleinman K; Placzek H; Lankiewicz JD; Platt R
Crit Care; 2011; 15(5):R210. PubMed ID: 21914221
[TBL] [Abstract][Full Text] [Related]
11. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
12. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
Cios K; Cohen B; Quittell LM; Liu J; Larson EL
Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
[TBL] [Abstract][Full Text] [Related]
13. Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor.
Singh SB; McLearn-Montz AJ; Milavetz F; Gates LK; Fox C; Murry LT; Sabus A; Porterfield HS; Fischer AJ
Pediatr Pulmonol; 2019 Aug; 54(8):1200-1208. PubMed ID: 31012285
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.
Harik NS; Com G; Tang X; Melguizo Castro M; Stemper ME; Carroll JL
Am J Infect Control; 2016 Apr; 44(4):409-15. PubMed ID: 26684366
[TBL] [Abstract][Full Text] [Related]
15. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
[TBL] [Abstract][Full Text] [Related]
17. [Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis].
Girón RM; Buendía B; Pinedo C; Casanova A; Hoyos N; Ancochea J
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):85-8. PubMed ID: 19254640
[TBL] [Abstract][Full Text] [Related]
18. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study.
Wood ME; Sherrard LJ; Ramsay KA; Yerkovich ST; Reid DW; Kidd TJ; Bell SC
BMC Pulm Med; 2016 May; 16(1):78. PubMed ID: 27170040
[TBL] [Abstract][Full Text] [Related]
20. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.
Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A
J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
